Hims & Hers Health, Inc. — Form 10-Q
Filed August 10, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 28/100
What the filing says
Hims & Hers Health, Inc. (Purchaser Parent) amended a Securities Sale Deed originally dated February 19, 2026 with Horizon BidCo Pty Ltd (Purchaser), Hims, Inc. (Guarantor), and multiple vendors/shareholders. The amendment, effective June 1, 2026, modifies earnout payment terms, adjustment statement procedures, payroll tax treatment, and option cancellation mechanics. Specific financial thresholds mentioned include earnout caps at 42% and 33% of aggregate amounts, revenue targets of $700M–$1B, and EBITDA targets of $28M–$40M across three earnout periods through 2028. No aggregate purchase price stated in this excerpt.
Why this rating
Amendment to M&A deal document; technical refinements to earnout mechanics and tax treatment. No new transaction announced; appears to be contractual clarification on existing February 2026 deal. Immaterial to $10.1B public company at this stage.
See more from August 10, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.